Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Systemic Absorption of Once Daily MOB015B When Applied for 28 Days in Subjects With Moderate to Severe Onychomycosis of the Toenails.

NCT03244280 is registered in ClinicalTrials.gov with Moberg Pharma AB as lead sponsor.

NCT NCT03244280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03244280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Systemic Absorption of Once Daily MOB015B When Applied for 28 Days in Subjects With Moderate to Severe Onychomycosis of the Toenails.
Lead sponsor
Moberg Pharma AB
Phase
Phase 1
Overall status
Completed
Start date
December 16, 2017
Completion date
April 23, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

onychomycosis